Croda International PLC Directorate Change (2037G)
23 July 2021 - 4:30PM
UK Regulatory
TIDMCRDA
RNS Number : 2037G
Croda International PLC
23 July 2021
23 July 2021
Croda International Plc
Appointment of Non-Executive Director
The Board of Croda International Plc is pleased to announce the
appointment of Julie Kim as non-executive director. Julie will join
the Board with effect from 1 September 2021.
Julie has over 25 years of experience in international
leadership positions in the healthcare industry, and is currently
President, Plasma-Derived Therapies at Takeda Pharmaceutical, a
global, values-based, R&D-driven biopharmaceutical leader
headquartered in Japan. Her geographic experience covers both
global and regional roles, focused on Europe, Asia and Latin
America. Prior to joining Takeda in 2019, Julie's previous
executive positions included roles such as Head of International
Market Access and Global Franchise Head of multiple therapeutic
areas at Shire, Baxalta and Baxter. Julie also sits on the industry
board for the Plasma Protein Therapeutics Association and started
her career in healthcare consulting.
On joining the Croda Board, Julie will also be appointed to the
Audit, Nomination and Remuneration Committees .
Anita Frew, Chair of Croda International Plc, said,
"I am delighted to welcome Julie to the Croda Board. Julie's
outstanding healthcare sector experience, her strong P&L
experience, and commercial R&D and manufacturing knowledge will
be of enormous benefit to Croda. She also brings even greater
diversity to the Board, in terms of gender, ethnicity, nationality
and tenure, as well as her tremendous skills and experiences as a
serving executive.
"Her appointment to the Board supports our strategic plans to
build our Life Sciences business and brand. With our focus on drug,
vaccine and crop delivery systems, Julie is ideally placed to help
deliver our ambition in these fast-growing markets."
There are no further matters to be disclosed under LR9.6.13R of
the Listing Rules of the UK Listing Authority.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
BOADZGZNVZNGMZM
(END) Dow Jones Newswires
July 23, 2021 02:30 ET (06:30 GMT)
Croda (LSE:CRDA)
Historical Stock Chart
From Apr 2024 to May 2024
Croda (LSE:CRDA)
Historical Stock Chart
From May 2023 to May 2024